Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study is a randomized, controlled, multi-center clinical study. The main purpose of this
study was to study the efficacy and safety data of total oral short-term therapy as an
alternative to injection in the treatment of newly diagnosed RR-TB patients.